N Engl J Med 2005,353(23):2442–2449 PubMedCrossRef 5 Goorhuis A,

N Engl J Med 2005,353(23):2442–2449.PubMedCrossRef 5. Goorhuis A, Van der Kooi T, Vaessen N, Dekker FW, Van den Berg R, Harmanus C, van den Hof S, Notermans DW, Kuijper EJ: Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in the Netherlands. Clin Infect Dis 2007,45(6):695–703.PubMedCrossRef selleck chemical 6. Hubert B, Loo VG, Bourgault AM, Poirier L, Dascal A, Fortin E, Dionne M, Lorange M: A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology

of C-difficile -associated disease in Quebec. Clin Infect Dis 2007,44(2):238–244.PubMedCrossRef 7. Redelings MD, Sorvillo RAD001 mw F, Mascola L: Increase in Clostridium difficile -related mortality rates, United States, 1999–2004. Emerg

Infect Dis 2007,13(9):1417–1419.PubMed 8. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D: Clostridium difficile -associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 2004,171(5):466–472.CrossRef 9. Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley TD, Sebaihia M, Quail MA, Rose G, Gerding DN, Gibert M, Popoff MR, Parkhill J, Dougan G, Wren BW: Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 2009.,10(9): 10. Lyerly DM, Phelps CJ, Toth J, Wilkins TD: Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun 1986,54(1):70–76.PubMed 11. Drudy D, Harnedy N, Fanning S, O’Mahony R, Kyne L: Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland. Clin Microbiol

Infect 2007,13(3):298–304.PubMedCrossRef 12. Kim H, Riley TV, Kim M, Kim CK, Yong D, Lee K, Chong Y, Park JW: Increasing prevalence of toxin A-negative, toxin B-positive isolates Astemizole of Clostridium difficile in Korea: Impact on laboratory diagnosis. J Clin Microbiol 2008,46(3):1116–1117.PubMedCrossRef 13. Scheline RR: Metabolism of selleck phenolic acids by rat intestinal microflora. Acta Pharmacol Toxicol (Copenh) 1968,26(2):189.CrossRef 14. Hafiz S, Oakley CL: Clostridium difficile : Isolation and characteristics. J Med Microbiol 1976,9(2):129–136.PubMedCrossRef 15. Selmer T, Andrei PI: p -Hydroxyphenylacetate decarboxylase from Clostridium difficile : A novel glycyl radical enzyme catalysing the formation of p -cresol. Eur J Biochem 2001,268(5):1363–1372.PubMedCrossRef 16.

Comments are closed.